Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Higher Kingston, United Kingdom Clinical Trials

A listing of Higher Kingston, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (6) clinical trials

Oral Liquid 13-cis-retinoic Acid (13-CRA)

All patients requiring at least two cycles of 13-CRA therapy will be eligible for recruitment into the trial. 13-CRA will be prescribed to patients according to local treatment protocols at each clinical site. The dose administered will be 200mg/m2/day for both test and reference product. Patients with a body weight ...

Phase

5.79 miles

Learn More »

A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

This study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration resistant prostate cancer.

Phase

6.19 miles

Learn More »

Neuromuscular Electrical Stimulation For The Treatment of Diabetic Peripheral Neuropathy

Diabetic peripheral neuropathy is a disabling condition, which is characterized by numbness, hypersensitivity or pain in the extremities. The cause is thought to be due to damaged nerves due to poor circulation. A new therapy option has recently become available to increase blood flow in the legs. The aim of ...

Phase N/A

6.22 miles

Learn More »

Evaluation of Speckle Tracking Parameters as Predictors of Successful VA SPECKLE ECMO

This project is non-commercial study which aims to assess whether measurements derived through speckle tracking give additional information to conventional echocardiographic parameters (LVOT VTI measurements, etc.) in identifying patients at greatest risk of major clinical events occurring within 30 days after VA ECMO liberation. It is a prospective observational non-blinded ...

Phase N/A

7.74 miles

Learn More »

Factor VIII Gene Therapy Study in Patients With Hemophilia A

The purpose of this study is to determine the safety and tolerability of the factor VIII gene transfer treatment with BAY 2599023 (DTX201) in individuals with severe hemophilia A.

Phase

9.81 miles

Learn More »

Moderato System in Patients With Hypertension

Protocol CS-03 Ver 1.1 (NCT02837445) was amended at the advice of the Scientific Advisory to protocol CS-03 Version 3.0 with more stringent hypertension inclusion criteria and different observation intervals for efficacy and safety. In CS-03 Version 3.0 the time of the primary efficacy endpoint was reduced from 6 months to ...

Phase N/A

9.81 miles

Learn More »